Stented Lich-Gregoir ureteroneocystostomy: Case series report and cost-effectiveness analysis

Richard Mangus, B. W. Haag, C. B. Carter

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Extravesical ureteroneocystostomy to reestablish urinary tract continuity in renal transplantation has been examined through a meta-analysis of more than 14,000 kidney transplants leading to the finding that stented anastomosis was associated with a lower urologic complication rate compared with nonstented anastomoses. Fourteen stents must be used to prevent one urologic complication. We now report the urologic complication rate in our case series in which a stented Lich-Gregoir anastomosis was routinely utilized. We present a cost-effectiveness analysis regarding the usage of ureteral stents. Methods. The records of 395 consecutive renal transplants were reviewed. Minimum follow-up time was 6 months. The standard anastomosis was a Lich-Gregoir with a 6- or 8-F 12- or 14-cm J-J stent. Monitored urologie complications included postoperative vesicoureteral leak or ureteral necrosis, obstruction or stricture, or clinically significant hematuria. Charges in 2004 US dollars were reported by the hospital accounting office. Results. Four urologic complications were noted-three leaks and one stricture (complication rate of 1.0%). There were no stent-reiated complications requiring reoperation. There were no cases in which the urologic complication led to graft loss or patient death. Total charges associated with stent use were $1,087 per patient, or $15,218 per urologic complication prevented. Conclusions. The urologic complication rate in this case series is similar to the five previously published randomized trials, as well as our previously published meta-analysis. These results support the routine use of a ureteral stent. Our analysis suggests that stent use is cost effective.

Original languageEnglish
Pages (from-to)2959-2961
Number of pages3
JournalTransplantation Proceedings
Volume36
Issue number10
DOIs
StatePublished - 2004

Fingerprint

Cost-Benefit Analysis
Stents
Transplants
Meta-Analysis
Pathologic Constriction
Kidney
Ureteral Obstruction
Hematuria
Urinary Tract
Reoperation
Kidney Transplantation
Necrosis
Costs and Cost Analysis

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Stented Lich-Gregoir ureteroneocystostomy : Case series report and cost-effectiveness analysis. / Mangus, Richard; Haag, B. W.; Carter, C. B.

In: Transplantation Proceedings, Vol. 36, No. 10, 2004, p. 2959-2961.

Research output: Contribution to journalArticle

@article{3f6b4ca5ac5e40dab761f2ad918958f9,
title = "Stented Lich-Gregoir ureteroneocystostomy: Case series report and cost-effectiveness analysis",
abstract = "Extravesical ureteroneocystostomy to reestablish urinary tract continuity in renal transplantation has been examined through a meta-analysis of more than 14,000 kidney transplants leading to the finding that stented anastomosis was associated with a lower urologic complication rate compared with nonstented anastomoses. Fourteen stents must be used to prevent one urologic complication. We now report the urologic complication rate in our case series in which a stented Lich-Gregoir anastomosis was routinely utilized. We present a cost-effectiveness analysis regarding the usage of ureteral stents. Methods. The records of 395 consecutive renal transplants were reviewed. Minimum follow-up time was 6 months. The standard anastomosis was a Lich-Gregoir with a 6- or 8-F 12- or 14-cm J-J stent. Monitored urologie complications included postoperative vesicoureteral leak or ureteral necrosis, obstruction or stricture, or clinically significant hematuria. Charges in 2004 US dollars were reported by the hospital accounting office. Results. Four urologic complications were noted-three leaks and one stricture (complication rate of 1.0{\%}). There were no stent-reiated complications requiring reoperation. There were no cases in which the urologic complication led to graft loss or patient death. Total charges associated with stent use were $1,087 per patient, or $15,218 per urologic complication prevented. Conclusions. The urologic complication rate in this case series is similar to the five previously published randomized trials, as well as our previously published meta-analysis. These results support the routine use of a ureteral stent. Our analysis suggests that stent use is cost effective.",
author = "Richard Mangus and Haag, {B. W.} and Carter, {C. B.}",
year = "2004",
doi = "10.1016/j.transproceed.2004.10.061",
language = "English",
volume = "36",
pages = "2959--2961",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "10",

}

TY - JOUR

T1 - Stented Lich-Gregoir ureteroneocystostomy

T2 - Case series report and cost-effectiveness analysis

AU - Mangus, Richard

AU - Haag, B. W.

AU - Carter, C. B.

PY - 2004

Y1 - 2004

N2 - Extravesical ureteroneocystostomy to reestablish urinary tract continuity in renal transplantation has been examined through a meta-analysis of more than 14,000 kidney transplants leading to the finding that stented anastomosis was associated with a lower urologic complication rate compared with nonstented anastomoses. Fourteen stents must be used to prevent one urologic complication. We now report the urologic complication rate in our case series in which a stented Lich-Gregoir anastomosis was routinely utilized. We present a cost-effectiveness analysis regarding the usage of ureteral stents. Methods. The records of 395 consecutive renal transplants were reviewed. Minimum follow-up time was 6 months. The standard anastomosis was a Lich-Gregoir with a 6- or 8-F 12- or 14-cm J-J stent. Monitored urologie complications included postoperative vesicoureteral leak or ureteral necrosis, obstruction or stricture, or clinically significant hematuria. Charges in 2004 US dollars were reported by the hospital accounting office. Results. Four urologic complications were noted-three leaks and one stricture (complication rate of 1.0%). There were no stent-reiated complications requiring reoperation. There were no cases in which the urologic complication led to graft loss or patient death. Total charges associated with stent use were $1,087 per patient, or $15,218 per urologic complication prevented. Conclusions. The urologic complication rate in this case series is similar to the five previously published randomized trials, as well as our previously published meta-analysis. These results support the routine use of a ureteral stent. Our analysis suggests that stent use is cost effective.

AB - Extravesical ureteroneocystostomy to reestablish urinary tract continuity in renal transplantation has been examined through a meta-analysis of more than 14,000 kidney transplants leading to the finding that stented anastomosis was associated with a lower urologic complication rate compared with nonstented anastomoses. Fourteen stents must be used to prevent one urologic complication. We now report the urologic complication rate in our case series in which a stented Lich-Gregoir anastomosis was routinely utilized. We present a cost-effectiveness analysis regarding the usage of ureteral stents. Methods. The records of 395 consecutive renal transplants were reviewed. Minimum follow-up time was 6 months. The standard anastomosis was a Lich-Gregoir with a 6- or 8-F 12- or 14-cm J-J stent. Monitored urologie complications included postoperative vesicoureteral leak or ureteral necrosis, obstruction or stricture, or clinically significant hematuria. Charges in 2004 US dollars were reported by the hospital accounting office. Results. Four urologic complications were noted-three leaks and one stricture (complication rate of 1.0%). There were no stent-reiated complications requiring reoperation. There were no cases in which the urologic complication led to graft loss or patient death. Total charges associated with stent use were $1,087 per patient, or $15,218 per urologic complication prevented. Conclusions. The urologic complication rate in this case series is similar to the five previously published randomized trials, as well as our previously published meta-analysis. These results support the routine use of a ureteral stent. Our analysis suggests that stent use is cost effective.

UR - http://www.scopus.com/inward/record.url?scp=21244473698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21244473698&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2004.10.061

DO - 10.1016/j.transproceed.2004.10.061

M3 - Article

C2 - 15686670

AN - SCOPUS:21244473698

VL - 36

SP - 2959

EP - 2961

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 10

ER -